Gamida Cell Ltd (GMDAQ)

[midastouch017]

Analysts Offer Insights on Healthcare Companies: Gamida Cell (GMDA), Onconova Therapeutics (ONTX) and Biogen (BIIB)
Jason Carr- August 13, 2020, 6:15 AM EDTSHARE ON:

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gamida Cell (GMDA), Onconova Therapeutics (ONTX) and Biogen (BIIB) with bullish sentiments.

Gamida Cell (GMDA)

In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Gamida Cell, with a price target of $15.00. The company’s shares closed last Wednesday at $4.10.

Gamida Cell has an analyst consensus of Strong Buy, with a price target consensus of $17.33, implying a 312.6% upside from current levels. In a report issued on August 11, Needham also assigned a Buy rating to the stock with a $17.00 price target.

https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-healthcare-companies-gamida-cell-gmda-onconova-therapeutics-ontx-and-biogen-biib/